Serum inflammatory biomarker profiles across the Alzheimer's disease spectrum in the Bio‐Hermes cohort

Abstract

Background: Neuroinflammation is an important contributor to Alzheimer’s disease (AD) pathogenesis. However, it is unclear whether inflammation drives, precedes, or occurs concurrently with AD pathology, and how inflammatory markers relate to established AD biomarkers.

The paper